Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases New High-CBD, Low-THC Gummies Designed to Address Pain, Stress and Anxiety

  • Plus Products releases PLUS CBDRelief brand into the California adult-use market
  • New product line currently includes two products: PLUS CBDRelief 9:1 Tropical Mango and PLUS CBDRelief 18:1
  • PLUS CBDRelief products specifically formulated to help reduce chronic subclinical inflammation, provide full-body relief and promote a calm state of mind

With its gummy products consistently ranking tops in California, the world’s largest cannabis market, Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is focusing its current efforts on maintaining its best-selling spot as well as expanding market share in a category that has historically remained underserved. PLUS plans to accomplish both with the launch of its newest line of products – two high-CBD, low-THC gummies designed to fill a hole in the wellness and relief-market cannabis category.

This month Plus Products released its PLUS CBDRelief brand into the California adult-use market ( The product line currently includes two products: PLUS CBDRelief 9:1 Tropical Mango with 9 mg of CBD and 1 mg of THC per serving and PLUS CBDRelief 18:1 Tart Cherry with 18 mg of CBD and 1 mg of THC per serving. The PLUS CBDRelief cannabis-infused gummies are expected to be…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.

Leave a Reply